Exact Sciences Laboratories, LLC
Exact Sciences Laboratories, LLC was paid $276.55M by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 81528, Oncology (colorectal) screening, quantitative real-time target and signal amplification — 100% of everything it billed.
MADISON, WI 53713
Next to other Clinical Medical Laboratory providers in Wisconsin
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,606 | $2.55M | |
| 2019 | 49,130 | $10.04M | |
| 2020 | 63,618 | $15.44M | |
| 2021 | 116,502 | $29.12M | |
| 2022 | 177,402 | $47.58M | |
| 2023 | 267,701 | $79.47M | |
| 2024incomplete | 290,455 | $92.35M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 81528 | Oncology (colorectal) screening, quantitative real-time target and signal amplification | 100% | 977,299 | 920,314 | $276.21M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 2,001 | 1,952 | $113K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 1,171 | 1,157 | $93K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 221 | 221 | $32K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 261 | 261 | $22K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 88 | 88 | $11K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 108 | 99 | $11K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 196 | 196 | $7K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 57 | 57 | $5K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 47 | 47 | $4K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 361 | 361 | $4K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 383 | 383 | $3K |
28 more codes
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 73 | $3K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 41 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 206 | $3K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 28 | $2K |
| 93000 | <1% | 91 | $1K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 12 | $1K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 12 | $1K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 13 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 60 | $1K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 55 | $969.65 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 12 | $914.48 |
| 20610 | <1% | 17 | $903.17 | |
| 87428 | <1% | 14 | $890.26 | |
| S3005 | Performance measurement, evaluation of patient self assessment, depression | <1% | 75 | $753.31 |
| 73610 | <1% | 35 | $738.85 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 13 | $732.94 |
| 97803 | <1% | 15 | $713.16 | |
| 73564 | <1% | 21 | $552.93 | |
| 73630 | <1% | 26 | $511.16 | |
| 81025 | <1% | 76 | $483.36 | |
| 81002 | <1% | 164 | $421.48 | |
| 73140 | <1% | 13 | $300.82 | |
| 73130 | <1% | 12 | $253.32 | |
| 90686 | <1% | 16 | $249.76 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 38 | $246.62 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 16 | $111.52 |
| 36415 | Collection of venous blood by venipuncture | <1% | 43 | $87.87 |
| 85018 | <1% | 24 | $50.56 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Genomic Health, INC. | Redwood City, CA | $96.56M |
| Exact Sciences Laboratories, LLC | Madison, WI | $652K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.